Advert

Another 29 medicines see price reductions

A reduction in the price of another 29 medicines has been announced by Parliamentary Secretary for Consumer Affairs Chris Said this morning.

The reduction follows talks with importers and will come into effect immediately on new stocks. It ranges from four to 30 per cent.

The price of seven medicines was reduced between four and 10 per cent, that of 17 between 11 and 20 per cent, that of four between 21 and 30 per cent and a medicine used to lower cholesterol in the blood was reduced by nearly 39 per cent.

Dr Said said that the new list includes medicines that are used a lot to cure heart diseases, hypertension, high cholesterol, stomach ulcers and acid, psoriasis, various inflammations and aches. Other medicines whose price has been reduced include antibiotics and medicines taken by people suffering from fits.

The Parliamentary Secretary said this development should lead to the final aim which was for medicine prices in Malta to reflect their economic value.

He said that since the publication of the first list of price reductions in July, when the price of another 61 medicines was reduced, the Consumer and Competition Department held 315 inspections at pharmacies. These were to continue to ensure that the reductions announced are put into effect.

Further information can be obtained from 2144 6446 Mondays to Fridays from 8 a.m. to 8 p.m., e-mail: medicines@gov.mt .

The list of medicines which are seeing a reduction in price follows:

Mediċina

Doża

Il-prezz l-antik (€)

Il-prezz il-ġdid (€)

Roħs (€)

Għal x'hiex tintuża

Atacand

28 tablets x 16mg

34.86

31.00

-3.86

pressjoni għolja

Cataflam®

20 coated tablets X 25mg

7.05

6.24

-0.81

uġiegħ u infjammazzjoni

Crestor

28 coated tablets X 10 mg

29.33

28.16

-1.17

ibaxxi l-kolesterol

Diprosalic scalp application

100ml Cutaneous solution X 2% + 0.05% w per w

24.25

21.46

-2.79

psoriasis fil-qurriegħa (ġilda tar-ras)

Elocon

30g Cream X 0.1% w per w

11.48

9.66

-1.82

infjammazzjoni tal-ġilda fi psoriasis

Elocon

30g Ointment x 0.1% w per w

11.48

9.66

-1.82

infjammazzjoni tal-ġilda fi psoriasis

Elocon

30ml Scalp Lotion X 0.1% + 30% w per w

11.48

9.66

-1.82

infjammazzjoni tal-ġilda fi psoriasis

Famvir

10 coated tablets X 125mg

45.11

37.45

-7.66

Antivirali

Fosrenol

90 chewable tablets X 750 mg

230.45

198.00

-32.45

jikkontrolla l-livelli tal-fosfat fid-demm f’pazjenti b’mard fil-kliewi

Fucithalmic

5g viscous eye drops solution X 10mg per g

6.64

5.32

-1.32

infezzjonijiet fl-għajnejn

Klacid® XL

7 modified release coated tablets X 500 mg

16.21

14.63

-1.58

Antibijotiku

Lescol® XL

28 prolonged release tablets X 80mg

39.73

33.29

-6.44

ibaxxi l-kolesterol

Losec® MUPS®

28 film-coated gastro resistant tablets X 10mg

32.12

25.70

-6.42

Kontra l-ulċeri u l-aċidu fl-istonku

Losec® MUPS®

28 film-coated gastro resistant tablets X 20mg

58.02

46.42

-11.60

Kontra l-ulċeri u aċidu fl-istonku

Simvacor

30 film coated tablets X 10 mg

17.54

10.71

-6.83

ibaxxi l-kolesterol

Subutex

7 sublingual tablets X 8mg

42.07

39.02

-3.05

sostitut li jinagħta lill-pazjenti li jieħdu id-drogi tat-tip opjojdi

Tegretol

50 tablets X 200mg

18.12

13.87

-4.25

Aċċessjonijiet

Tenoretic®

28 film coated tablets X 100mg + 25mg

15.89

11.12

-4.77

pressjoni għolja

Tenormin

28 film-coated tablets X 100mg

12.30

9.90

-2.40

pressjoni għolja

Voltaren®

5 Suppositories X 100mg

8.51

7.63

-0.88

uġiegħ u infjammazzjoni

Voltaren®

30 gastro-resistant tablets X 25mg

9.65

8.32

-1.33

Uġiegħ u infjammazzjoni

Voltaren®

10 suppositories X 12.5mg

6.76

6.24

-0.52

Uġiegħ u infjammazzjoni

Voltaren®

10 suppositories X 50mg

8.97

7.63

-1.34

Uġiegħ u infjammazzjoni

Voltaren®

5 X 3ml ampoules of 75mg

12.24

10.40

-1.84

Uġiegħ u infjammazzjoni

Voltaren® Retard 100

10 modified release tablet X 100mg

10.61

9.71

-0.90

uġiegħ u infjammazzjoni

Zestoretic 20

28 tablets X 20mg + 12.5mg

25.60

18.34

-7.26

pressjoni għolja

Zestril

28 tablets X 5mg

11.37

10.46

-0.91

pressjoni għolja jew mard tal-qalb

Zestril

28 tablets X 10mg

17.33

14.73

-2.60

pressjoni għolja jew mard tal-qalb

Zestril

28 tablets X 20mg

25.60

19.20

-6.40

pressjoni għolja jew mard tal-qalb

Advert

36 Comments

Post comment

Comments are submitted under the express understanding and condition that the editor may, and is authorised to, disclose any/all of the above personal information to any person or entity requesting the information for the purposes of legal action on grounds that such person or entity is aggrieved by any comment so submitted.

At this time your comment will not be displayed immediately upon posting. Please allow some time for your comment to be moderated before it is displayed.

Your User Profile is incomplete.
Please click here to complete your profile before posting comments.

j.quintano

Sep 2nd 2010, 15:59

i assure you that competition is fierce in the market. Big pharmaceutical agents wont feel the pinch of the reduction in prices because they have got a wide variety of products and the loss incurred on them will be minimal. No businessman is crazy enough to be at a loss. However people have to be instructed by both doctors and pharmacists on which medicinal product is the most cost effective for them.

M.Cachia

Sep 1st 2010, 19:25

Madam do you expect pharmacies that would have bought their stock at a higher price to begin selling it at the lower price? This would entail either minimal profit, or in most cases a loss. At the end of the day the pharmacist's wage and utitlities have to be paid and therefore a profit must be had. It's only when agent's refund the difference in price to the pharmacies that the prices can go down overnight.

M.Cachia

Sep 1st 2010, 16:34

Funny that - And UK holidaymakers always go to maltese pharmacies to stock up on Ventolin because it's cheaper than in the UK.

ppace

Sep 1st 2010, 19:43

Dont tell me you consider Ventolin expensive ta!

V Zammit

Sep 1st 2010, 17:00

Mr Stafrace,
Good for you.
And the price for the same packet - Doxazosin - in London is Sterling 3.20, today, September 1, 2010.

M.Cachia

Sep 1st 2010, 19:20

All Cardura is Doxazosin but not all Doxazosin is Cardura. It's that cheap because it's a generic which might or might not be of the same quality as Cardura.

V. Zammit

Sep 2nd 2010, 02:01

M. Cachia
A generic is a drug which is produced and distributed without patent protection. It may still have a patent on the formulation but not on the active ingredient. It must contain, too, the same active ingredients as the original formulation. Generic drugs are identical or within an acceptable bioequivalent range to the brand name counterpart with respect to pharmacokinetic and pharmacodynamic properties. By extension, therefore, generics are identical in dose, strength, route of administration, safety, efficacy, and intended use. In most cases, generic products are available once the patent protections afforded to the original developer have expired. When generic products become available, the market competition often leads to substantially lower prices for both the original brand name product and the generic forms. There is no market competition locally in this respect. Which may or may not account for the price, not the quality, being what it is for the formerly patented product.

S. Vella

Sep 2nd 2010, 08:42

@M. Cachia

Any generic sold in a EU market is of the same quality of the originator (in this case Cardura). The reason generics are cheaper is simply because they are allowed to bypass the most expensive research stages - animal testing and human clinical trials.

The days of bad quality generics have been over by more than a decade unless you do not buy from an unlicensed (stress on UNlicensed) e-pharmacy.

M.Cachia

Sep 2nd 2010, 14:45

Not so - not all generics are identical to the the parent drug (in this case Cardura). While they are identical in dose, strength, route of administration and safety, generics have a range of efficacy which they must fall in to be licensed. While some generics are equivalent or better than the parent drug, some are not because thier efficacy and bioequivalence fall into the lower end of this bracket. In simple terms the excipient mix is not the same as the parent's so degranulation and therefore absorbtion rates will also differ. I am not against generics, but you do have to carefully select which generics to trust.

And in case you don't believe me - from experience, I've had 6 patients in the last year who have to take Cardura as the generic available fromt he NHS has only limited efficacy in controling thier prostatic hyperplasia.

Claire Busuttil

Sep 1st 2010, 16:11

kemm tidher li qatt ma kellek bzonn medicini jew servizzi tas sahha.....kieku mhux il kulur titlef....imbad naraw kemm tibqa tara kollox bil blu!!

Claire Busuttil

Sep 1st 2010, 21:55

@ sorry this comment was meant for Mr.XERRI

K. Crockford

Sep 1st 2010, 13:03

So you're thinking that these importers just reduced their prices out of nothing, the likely reason is because they had a VERY big profit over them(since they were over priced).

"The Parliamentary Secretary said this development should lead to the final aim which was for medicine prices in Malta to reflect their economic value."

here itself proves that the medicine is not of its economical value.. ie its OVER priced

B.Grech

Sep 1st 2010, 13:05

@ 'Tilaghbuha tal-indipendneti. Imma ovvja li taghmlu hekk ghax ta' kulur differenti u mmexxija mill-politika partiggjana. Min jitwieled tond ma jmutx kwadru. ' From this comment I m sure you must be over 50 years old. The younger generations are no longer led by the nose by one party or the other. In this case yes its a good thing that some sort of price control is being introduced but we ordinary people have every right to be angry at why it took so many years to happen not to mention suspicious of whether the process has gone far enough.

T Camilleri

Sep 1st 2010, 16:43

Very jaghmuk mix-xejn P. J. Xerri

M.Cachia

Sep 1st 2010, 14:32

You do realise that what you described is all paid by the mother company not the agents, so all that's going to change is that the agents have less money going into thier pockets, which is only fair.

T Camilleri

Sep 1st 2010, 16:45

M.Cachia pull the other one Cachia. And do you think that the mother company would just throw all this money without getting much more back from un-necessary prescriptions by the professionals?

M.Cachia

Sep 1st 2010, 19:17

Of course they get something in return - do you think they do it to be nice? That was not the point of my comment. The point was that what Mr. Vella mentioned is paid from profits made by the mother company not by profits made by the agents, so this reduction in prices at the local level will not have any bearing on them whatsoever.

Advert
Advert